Israeli Citizens File Class Action Against Vioxx
The Chicago-based Kenneth B. Moll & Associates Ltd. law firm has filed a class action on behalf of all Israeli citizens who have allegedly died or were seriously hurt from using the pain-killing drug Vioxx.
The lawsuit accuses the drug manufacturer, Merck & Co., Inc., of not conducting adequate research regarding Vioxx’s known risks and of not warning Israeli consumers against potential lethal side effects.
About a year ago Merck decided, on its own initiative, to yank the drug from pharmacy shelves all over the world, following a comprehensive research published by the FDA, which discovered that Vioxx increases the risk of heart attacks and strokes. This was followed by a series of lawsuits against the company as was expected.
Attorney Moll said that Merck’s decision to remove the drug from the market came years after the company first found out about the drug’s health risks. Attorney Moll claims that the court’s ruling clearly shows that Merck is guilty for its decision to prefer its profits over the safety of its consumers.
Merck presented a strong financial picture despite Vioxx withdrawal. It said it expects earnings per share for 2005 to total $US2.47 to $US2.51, excluding a charge taken in the second quarter. For the first nine months of 2005, net income was $US3.51 billion, or $US1.59 per share.
Filed under Class Action
You may also like to read
- Vioxx Lawsuit Update - Consumer Perspective
- Jury Hears Closing Arguments in Vioxx Class Action Lawsuit at NJ
- Appeal on Vioxx Class Action Lawsuit Granted in New Jersey's Supreme Court
- Vioxx Class Action Lawsuit Was Rejected in New Jersey
- Vioxx Formula is Key To The Trial
- New Jersey Trial Over Vioxx Ended With Merck's Victory
- Mistrial in Vioxx Class Action Lawsuit in Houston
- Analysis of Class Action Law Suits Against Merck for Vioxx
- Double Setback in Vioxx Class Action Lawsuit
- Merck Faces Second Class Action Lawsuit Over The Pain Killer Case
